BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mccaughan JA, Tinckam KJ. Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management. Transpl Int 2018;31:1059-70. [DOI: 10.1111/tri.13324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Barten MJ, Zuckermann A. The meaning of donor-specific antibodies after heart transplant. Curr Opin Organ Transplant 2019;24:252-8. [PMID: 31090632 DOI: 10.1097/MOT.0000000000000641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
2 Aversa M, Benvenuto L, Kim H, Shah L, Robbins H, Stanifer BP, D'Ovidio F, Vasilescu ER, Sonett J, Arcasoy SM. Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates. Ann Transplant 2019;24:383-92. [PMID: 31249284 DOI: 10.12659/AOT.915769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Vionnet J, Sempoux C, Pascual M, Sánchez-fueyo A, Colmenero J. Donor-specific antibodies in liver transplantation. Gastroenterología y Hepatología 2020;43:34-45. [DOI: 10.1016/j.gastrohep.2019.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
4 Aversa M, Martinu T, Patriquin C, Cypel M, Barth D, Ghany R, Ma J, Keshavjee S, Singer LG, Tinckam K. Long-term outcomes of sensitized lung transplant recipients after peri-operative desensitization. Am J Transplant 2021. [PMID: 34058795 DOI: 10.1111/ajt.16707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Götz JK, Kiene H, Goldschmidt I, Junge N, Pfister ED, Leiskau C, Brown RM, Immenschuh S, Baumann U. Current Evidence on the Clinical Relevance of Donor-specific Antibodies in Paediatric Liver Transplantation. J Pediatr Gastroenterol Nutr 2021;72:788-93. [PMID: 33908737 DOI: 10.1097/MPG.0000000000003127] [Reference Citation Analysis]
6 Ius F, Haverich A, Warnecke G. Cardiac Transplantation Across Preformed HLA-antibody Barriers. Transplantation 2019;103:1304-5. [PMID: 30365466 DOI: 10.1097/TP.0000000000002504] [Reference Citation Analysis]
7 Lebraud E, Eloudzeri M, Rabant M, Lamarthée B, Anglicheau D. Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms. Front Immunol 2022;13:864730. [PMID: 35392097 DOI: 10.3389/fimmu.2022.864730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sacreas A, Taupin JL, Emonds MP, Daniëls L, Van Raemdonck DE, Vos R, Verleden GM, Vanaudenaerde BM, Roux A, Verleden SE; the Leuven Lung Transplant Group. Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction. Eur Respir J 2019;54:1900847. [PMID: 31439680 DOI: 10.1183/13993003.00847-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Rosser C, Sage D. Approaches for the characterization of clinically relevant pre-transplant human leucocyte antigen (HLA) antibodies in solid organ transplant patients. Int J Immunogenet 2021. [PMID: 34346180 DOI: 10.1111/iji.12552] [Reference Citation Analysis]
10 Guo Y, Song S, DU X, Tian L, Zhang M, Zhou H, Chen ZK, Chang S. Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1α-XBP1 pathway. J Zhejiang Univ Sci B 2022;23:392-406. [PMID: 35557040 DOI: 10.1631/jzus.B2100780] [Reference Citation Analysis]
11 Fujiyama N, Satoh S, Saito M, Numakura K, Inoue T, Yamamoto R, Saito T, Nara T, Kanda S, Narita S, Kagaya H, Miura M, Habuchi T. Association of immunosuppressive agents and cytomegalovirus infection with de novo donor-specific antibody development within 1 year after renal transplantation. Int Immunopharmacol 2019;76:105881. [PMID: 31520989 DOI: 10.1016/j.intimp.2019.105881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Sacreas A, Verleden SE. High-resolution human leukocyte antigen typing and early post-transplant outcomes: more than meets the eye. Ann Transl Med 2020;8:46. [PMID: 32154808 DOI: 10.21037/atm.2020.01.110] [Reference Citation Analysis]
13 Njue F, Chih S. When to intervene for donor-specific antibody after heart transplantation. Curr Opin Organ Transplant 2019;24:271-8. [PMID: 31090635 DOI: 10.1097/MOT.0000000000000634] [Reference Citation Analysis]